Search the Newsreel

Aardvark Therapeutics Reports Q2 2026 Results, Updates ARD-101 PWS Program and FDA Discussions

Aardvark Therapeutics announced its Q2 2026 financial results, reporting a net loss of $14.4 million and a cash position of $73.9 million, sufficient to fund operations into late 2027. The company is actively engaging with the FDA to resolve a clinical hold on its …

Aardvark Therapeutics, Inc. Q2 2026: Net loss $14.4M, EPS $(0.66) — 10-Q Summary

Aardvark Therapeutics, Inc. reported a net loss of $14.4 million, or $(0.66) per diluted share, for Q2 2026, consistent with the prior year. Cash and cash equivalents increased to $73.8 million. Clinical trials for ARD-101 and ARD-201 were paused due to cardiac observations, leading …

Savara (NASDAQ:SVRA) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Savara (NASDAQ:SVRA) announced its quarterly earnings, reporting a loss of $0.16 per share, which missed the consensus estimate by $0.02. Shares fell by $0.16 to $5.57 during Tuesday trading. The company maintains a "Moderate Buy" consensus rating from analysts, with an average target price …

Harvard Bioscience (NASDAQ: HBIO) grows Q2 sales but faces higher debt costs

Harvard Bioscience (NASDAQ: HBIO) reported an 11.1% increase in Q2 2026 revenue, reaching $22.7 million, primarily driven by strong sales to CROs in the Americas and distributors in Asia-Pacific. Despite revenue growth and ongoing cost-saving initiatives like "Project Viking," the company posted a net …

HARVARD BIOSCIENCE INC 2026: Revenue $22.73M, EPS ($0.64) — 10-Q Summary

HARVARD BIOSCIENCE INC (HBIO) reported its second-quarter 2026 results, showing an 11.1% year-over-year revenue increase to $22.73M. Despite this growth, the company recorded a net loss of ($2.91M) and a diluted loss per share of ($0.64). The revenue growth was primarily driven by increased …

Is Teledyne Technologies (TDY) Fairly Valued As It Buys Varex Imaging?

Harvard Bioscience targets 3% to 5% full-year 2026 revenue growth as CMT and China mix shifts gross margin to 57% to 59%

Earnings Call Insights: Harvard Bioscience (HBIO) Q2 2026 MANAGEMENT VIEW * "That disciplined focus and execution helped us deliver strong second quarter performance, highlighted by double-digit revenue growth across our CMT and preclinical portfolios and solid operational execution that reinforced our confidence in raising …

Vardhman Special Steels hosts investor meet in Mumbai on Aug 14

Varex Imaging (NASDAQ:VREX) Sees Strong Trading Volume After Strong Earnings

Kolchinsky Warns Ban on Chinese Biotech Deals Would Hand Pipeline to Novartis

A debate in Boston featured RA Capital founder Peter Kolchinsky and Ginkgo Bioworks CEO Jason Kelly discussing whether the U.S. should ban in-licensing of drug assets from China. Kelly argued the U.S. has significant leverage due to its pharmaceutical revenue share, while Kolchinsky warned …

Harvard Bioscience beats estimates, raises 2026 guidance

Harvard Bioscience Inc. (NASDAQ:HBIO) surpassed analyst expectations for its second-quarter 2026 results, reporting adjusted EPS of -$0.14 and revenue of $22.7 million, exceeding estimates. The company also raised its full-year 2026 revenue guidance to 3%-5% YoY growth, citing strong demand for its telemetry and …

Harvard Bioscience (HBIO) grows Q2 2026 sales but stays in loss

Harvard Bioscience (HBIO) reported an 11.1% increase in Q2 2026 revenue, reaching $22.7 million, with full-year revenue guidance raised to 3%-5% growth. Despite top-line expansion and improved gross margins, the company remains unprofitable, recording a Q2 2026 net loss of $2.9 million. Operating cash …

Teledyne agrees to acquire Varex Imaging for $1.1bn

Teledyne Technologies has entered a definitive agreement to purchase Varex Imaging in a cash transaction valued at nearly $1.1bn. Under the terms announced by both companies, Teledyne will purchase all outstanding common shares of Varex for $18.90 per share. The agreed price includes consideration …

Harvard Bioscience Q2 Revenue Rises 11 Percent to $22.7 Million

Harvard Bioscience (HBIO) reported an 11% increase in Q2 2026 revenue, reaching $22.7 million, despite a GAAP net loss of $2.9 million. The company also raised its full-year 2026 revenue guidance to 3% to 5% growth. Insider trading data shows multiple purchases of HBIO …

Harvard Bioscience Lifts 2026 Revenue Outlook After 11% Q2 Growth

Harvard Bioscience (HBIO) reported an 11% year-over-year revenue increase to $22.7 million in Q2 2026, leading them to raise their full-year 2026 revenue growth guidance to 3-5%. Despite a widened GAAP net loss, adjusted EBITDA saw growth, and the company provided Q3 2026 revenue …

NOVN Stock Price and Chart — SIX:NOVN

This page provides a comprehensive overview of Novartis AG (NOVN) stock, listed on the SIX Swiss Exchange. It includes real-time price data, key financial statistics, upcoming earnings information, company details, and an archive of recent news and analyst ideas related to the stock. The …

Varex Imaging Corporation Stock 12‑Month Price Target Cut to $17.58, Implies 42% Upside

The average 12-month price target for Varex Imaging Corporation (VREX) stock has been lowered from $18 to $17.58 by 5 analysts, with individual forecasts ranging from $12 to $20 per share. This new target suggests a potential upside of approximately 42% from its August …

Vardhman Polytex profit surges 757% in Q1FY27 on debt settlement gain

Harvard Bioscience (HBIO) Earnings Date and Reports 2026

Savara (SVRA) Earnings Date and Reports 2026

Varex Imaging Corp (VREX) Earnings Forecast: Future EPS & Revenue Growth Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Varroc Engineering Limited (VARROC.NS) stock price, news, quote and history

Varex Imaging Agrees to Teledyne All-Cash Acquisition

Varex Imaging has agreed to be acquired by Teledyne Technologies in an all-cash deal valued at approximately $1.1 billion. The acquisition, pending shareholder and regulatory approvals, will result in Varex becoming a wholly-owned subsidiary of Teledyne and its delisting from Nasdaq in early 2027. …

Varonis Systems Number of Employees 2026 | Employee Count & Headcount Data

Varonis Systems, Inc. (VRNS) had approximately 2,729 total employees worldwide as of March 2026, representing a 13.5% growth since 2023. The company is actively hiring, with 160 active job postings in 2026. The average salary is $125,817, and North America holds the largest concentration …

VREX|Varex Imaging Corp|Price:18.450|Chg%:+6.040

AlTi Global (NASDAQ:ALTI) Issues Quarterly Earnings Results

Teledyne to acquire Varex Imaging in $1.1 billion deal

Teledyne Technologies announced its agreement to acquire Varex Imaging Corporation for approximately $1.1 billion. This acquisition will significantly expand Teledyne's medical and industrial X-ray imaging portfolio by adding Varex's X-ray tubes, digital X-ray detectors, and advanced photon-counting detectors. The deal, representing an 88% premium …

Varex Imaging downgraded to Neutral from Buy at B. Riley

B. Riley downgraded Varex Imaging (VREX) to Neutral from Buy, increasing the price target slightly to $18.90 from $18.00. This change comes after Varex Imaging agreed to be acquired by Teledyne Technologies for $18.90 per share in cash, leaving limited upside potential without a …

Varex Imaging (VREX) swings to profit and plans $18.90-per-share sale to Teledyne

Varonis to Webcast Sept. 9 Presentation From New York Conference

Varonis (Nasdaq: VRNS) announced it will present at Citi's 2026 Global TMT Conference in New York on September 9, 2026, at 1:55 p.m. ET. A live audio webcast and archive of the presentation will be available on the Investor Relations section of the company's …

Varonis to Present at Upcoming Investor Conference

Varonis Systems, Inc. (Nasdaq: VRNS) announced its participation in Citi's 2026 Global TMT Conference from September 8-10 in New York. The company's presentation is scheduled for September 9 at 1:55 p.m. ET, and an audio webcast will be available on their investor relations website. …

Why Savaria Corporation stock is sliding today

Varex Imaging earnings beat by $0.10, revenue fell short of estimates

Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Hi

Varex Imaging Corp (NASDAQ: VREX) saw its shares jump 48.4% after reporting better-than-expected Q3 earnings, beating analyst estimates for EPS but missing on sales. The company also announced it would be acquired by Teledyne. Several other companies, including Bowman Consulting Group Ltd, MarineMax Inc, …

Varex Imaging (NASDAQ:VREX) Rises 48% After Teledyne Bids $18.90 Per Share in Cash

Varex Imaging (NASDAQ:VREX) Sets New 52-Week High on Strong Earnings